Patient-Centered Outcomes Research Institute Awards $70 Million for Research Projects | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Patient-Centered Outcomes Research Institute Awards $70 Million for Research Projects

January 27, 2016
by Heather Landi
| Reprints

The Patient-Centered Outcomes Research Institute (PCORI) board of governors approved $70 million for nine new patient-centered research projects focused on conditions ranging from diabetes to chronic lung disease and migraines.

The Patient-Centered Outcomes Research Institute (PCORI) is an independent, non-profit organization authorized by Congress in 2010 and its focus is to fund research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed healthcare decisions.

With these latest awards, PCORI has now approved or awarded more than $1.2 billion in research funding.

Of the $70 million approved, $6.7 million will go to three of the Clinical Data Research Networks (CDRNs) that are members of PCORnet, PCORI’s initiative to develop a national patient-centered clinical research network. The awards will help the recipients study the impact of population-targeted health policies and interventions on risks, complications and disparities related to type II diabetes. Their projects will be part of the newly announced Natural Experiments Network, a joint effort of PCORI, the U.S. Centers for Disease Control and Prevention, and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health. NEN study findings are meant to inform policy makers’, health plan directors’ and community leaders’ efforts to prioritize policies and other actions to prevent diabetes. 

Five of the awards are the latest in PCORI's initiative to support “pragmatic clinical studies.” These studies aim to produce results that are more relevant to a broad range of patients and care settings and easier to adopt in routine practice. They are conducted in routine clinical settings, rather than in specialized research centers, and involve participants who more closely mirror typical patients.

The newly approved pragmatic studies will compare: 

  • Active surveillance versus traditional treatment options, such as surgery and radiation, for patients diagnosed with DCIS.
  • The effectiveness of two medications – roflumilast and azithromycin – commonly used to treat patients with chronic obstructive pulmonary disease (COPD).
  • The effectiveness of different approaches involving community health workers, tailored education, and other means to help adults with serious mental illness quit smoking.
  • The effectiveness of daily use of an inhaled corticosteroid versus symptom-based use for reducing asthma exacerbations in African American and Hispanic adults with asthma.
  • The effectiveness of two approaches to help people manage their chronic migraines and reduce the risk of medication overuse.  

“We’re strongly committed to supporting large-scale projects that will provide patients and those who care for them with the useful, authoritative evidence they need to make the better-informed health and health care decisions,” PCORI Executive Director Joe Selby, M.D., said in a statement.

Each study will involve national advocacy organizations, major professional societies and associations, payers and other key patient and stakeholder groups, in their research design and implementation.

PCORI also approved $5.2 million for a study that addresses PCORI’s priority to fund research on improving healthcare systems. This study will determine whether encouraging text messages or working with diabetes wellness coaches is more effective at helping African Americans with uncontrolled diabetes manage their conditions.

In addition, the board authorized a supplemental $3.8 million in funding for the ADAPTABLE trial, a PCORnet study that aims to identify the optimal dose of aspirin to prevent heart attacks and strokes in patients with heart disease.

 

 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Study will Leverage Connecticut HIE to Help Prevent Suicides

A new study will aim to leverage CTHealthLink, a physician-led health information exchange (HIE) in Connecticut, to help identify the factors leading to suicide and to ultimately help prevent those deaths.

Duke Health First to Achieve HIMSS Stage 7 Rating in Analytics

North Carolina-based Duke Health has become the first U.S. healthcare institution to be awarded the highest honor for analytic capabilities by HIMSS Analytics.

NIH Releases First Dataset from Adolescent Brain Development Study

The National Institutes of Health (NIH) announced the release of the first dataset from the Adolescent Brain Cognitive Development (ABCD) study, which will enable scientists to conduct research on the many factors that influence brain, cognitive, social, and emotional development.

Boston Children's Accelerates Data-Driven Approach to Clinical Research

In an effort to bring a more data-driven approach to clinical research, Boston Children’s Hospital has joined the TriNetX global health research network.

Paper Records, Films Most Common Type of Healthcare Data Breach, Study Finds

Despite the high level of hospital adoption of electronic health records and federal incentives to do so, paper and films were the most frequent location of breached data in hospitals, according to a recent study.

AHA Appoints Senior Advisor for Cybersecurity and Risk

The American Hospital Association (AHA) has announced that John Riggi has joined the association as senior advisor for cybersecurity and risk.